Association of STAT4 polymorphisms with susceptibility to primary membranous glomerulonephritis and renal failure

Clinica Chimica Acta

Volumn 412, Issue 21-22, 2011, Pages 1899-1904

  Chen, Shih Yin ^a,b   Chen, Cheng Hsu ^c   Huang, Yu Chuen ^a,b   Chan, Chia Jung ^a   Hsieh, Yao Yuan ^b,d   Yu, Min Chien ^f   Tsai, Chang Hai ^a   Tsai, Fuu Jen ^a,e  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d Hsieh Yao Yuan Womens' Hospital   (Taiwan)

^e ASIA UNIVERSITY   (Taiwan)

^f CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Haplotype; Membranous glomerulonephritis (MGN); Signal transducer and activator of transcription 4 (STAT4); Single nucleotide polymorphisms (SNPs)

Indexed keywords

STAT4 PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENE; GENE FREQUENCY; GENOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; PATHOGENESIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STAT4 GENE; TAIWAN;

ALLELES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; RENAL INSUFFICIENCY; RISK FACTORS; STAT4 TRANSCRIPTION FACTOR;

EID: 80051675497     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.06.020     Document Type: Article

References (35)

1. Lewis E.J. Management of nephrotic syndrome in adults. The nephrotic syndrome 1988, 461-521. Marcel Dekker, New York. J.S. Cameron, R.J. Glassock (Eds.).
2. Schieppati A., Mosconi L., Perna A., et al. Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med 1993, 329:85-89.
3. Philibert D., Cattran D. Remission of proteinuria in primary glomerulonephritis: we know the goal but do we know the price?. Nat Clin Pract Nephrol 2008, 4:550-559.
4. Glassock R.J. Diagnosis and natural course of membranous nephropathy. Semin Nephrol 2003, 23:324-332.
5. Ponticelli C. Membranous nephropathy. J Nephrol 2007, 20:268-287.
6. Chen K.H., Chang C.T., Hung C.C. Glomerulonephritis associated with chronic inflammatory demyelinating polyneuropathy. Ren Fail 2006, 28:255-259.
7. Yen T.H., Huang J.Y., Chen C.Y. Unexpected IgA nephropathy during the treatment of a young woman with idiopathic dermatomyositis: case report and review of the literature. J Nephrol 2003, 16:148-153.
8. Ihle J.N. The Stat family in cytokine signaling. Curr Opin Cell Biol 2001, 13:211-217.
9. Watford W.T., Hissong B.D., Bream J.H., Kanno Y., Muul L., O'Shea J.J. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol Rev 2004, 202:139-156.
10. Skapenko A., Leipe J., Lipsky P.E., Schulze-Koops H. The role of the T cell in autoimmune inflammation. Arthritis Res Ther 2005, 7(Suppl 2):S4-S14.
11. Mathur A.N., Chang H.C., Zisoulis D.G., et al. STAT3 and STAT4 direct development of IL-17-secreting Th cells. J Immunol 2007, 178:4901-4907.
12. Bettelli E., Oukka M., Kuchroo V.K. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007, 8:345-350.
13. Gaffen S.L., Kramer J.M., Yu J.J., Shen F. The IL-17 cytokine family. Vitam Horm 2006, 74:255-282.
14. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 2007, 13:139-145.
15. Kobayashi S., Ikari K., Kaneko H., et al. Association of STAT4 with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese population. Arthritis Rheum 2008, 58:1940-1946.
16. Korman B.D., Alba M.I., Le J.M., et al. Variant form of STAT4 is associated with primary Sjogren's syndrome. Genes Immun 2008, 9:267-270.
17. Remmers E.F., Plenge R.M., Lee A.T., et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007, 357:977-986.
18. Rueda B., Broen J., Simeon C., et al. The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype. Hum Mol Genet 2009, 18:2071-2077.
19. Zervou M.I., Mamoulakis D., Panierakis C., Boumpas D.T., Goulielmos G.N. STAT4: a risk factor for type 1 diabetes?. Hum Immunol 2008, 69:647-650.
20. Ehrenreich T., Porush J.G., Churg J., et al. Treatment of idiopathic membranous nephropathy. N Engl J Med 1976, 295:741-746.
21. Wakai S., Magil A.B. Focal glomerulosclerosis in idiopathic membranous glomerulonephritis. Kidney Int 1992, 41:428-434.
22. Haas M. Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidey Dis 1997, 29:829-842.
23. Maisonneuve P., Agodoa L., Gellert R., et al. Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study. Am J Kidney Dis 2000, 35:157-165.
24. Jiménez A., Sánchez B., Pérez Alenza D., et al. Membranous glomerulonephritis in the Iberian lynx. Vet Immunol Immunopathol 2008, 121:34-43.
25. Chen C.H., Shu K.H., Wen M.C., et al. Impact of plasminogen activator inhibitor-1 gene polymorphisms on primary membranous nephropathy. Nephrol Dial Transplant 2008, 23:3166-3173.
26. Bantis C., Heering P.J., Aker S., et al. Tumor necrosis factor-alpha gene G-308A polymorphism is a risk factor for the development of membranous glomerulonephritis. Am J Nephrol 2006, 26:12-15.
27. Cattran D.C. Idiopathic membranous glomerulonephritis. Kidney Int 2001, 59:1983-1994.
28. Stratta P., Bermond F., Guarrera S., et al. Interaction between gene polymorphisms of nitric oxide synthase and renin-angiotensin system in the progression of membranous glomerulonephritis. Nephrol Dial Transplant 2004, 19:587-595.
29. Schindler C., Levy D.E., Decker T. JAK-STAT signaling: from interferons to cytokines. J Biol Chem 2007, 282:20059-20063.
30. Bacon C.M., Petricoin E.F., Ortaldo J.R., et al. Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc Natl Acad Sci U S A 1995, 92:7307-7311.
31. Jacobson N.G., Szabo S.J., Weber-Nordt R.M., et al. Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat) 3 and Stat4. J Exp Med 1995, 181:1755-1762.
32. Kaplan M.H., Sun Y.L., Hoey T., Grusby M.J. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 1996, 382:174-177.
33. Chang H.C., Zhang S., Kaplan M.H. Neonatal tolerance in the absence of Stat4- and Stat6-dependent Th cell differentiation. J Immunol 2002, 169:4124-4128.
34. Sigurdsson S., Nordmark G., Garnier S., et al. A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5. Hum Mol Genet 2008, 17:2868-2876.
35. Sperati C.J., Parekh R.S., Berthier-Schaad Y., et al. Association of single-nucleotide polymorphisms in JAK3, STAT4, and STAT6 with new cardiovascular events in incident dialysis patients. Am J Kidney Dis 2009, 53:845-855.